Monitoring for Paralysis After Anesthesia
(QUANTUM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two methods to monitor patients after surgery to determine which better identifies low oxygen levels. One method uses detailed tools (quantitative monitoring), while the other uses simpler ones (qualitative monitoring). The goal is to determine which method aids faster recovery after surgery. The trial seeks adults undergoing surgery with general anesthesia and a muscle relaxant called rocuronium. It excludes those already intubated before surgery or with certain medical devices or conditions. As an unphased trial, it offers patients the chance to contribute to enhancing post-surgical care and recovery methods.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these monitoring techniques are safe for surgical patients?
Studies have shown that using quantitative monitoring during surgery is safe and reduces the risk of muscle weakness afterward. For example, one study found that this monitoring significantly lowers the chances of residual muscle paralysis post-operation, meaning patients are less likely to wake up with impaired muscle function.
Another study found that quantitative monitoring enhances anesthesia safety by providing precise information on muscle activity during surgery, helping doctors ensure patients wake up as expected.
Overall, research supports that quantitative monitoring is well-tolerated and improves surgical safety by ensuring proper muscle function upon waking.12345Why are researchers excited about this trial?
Researchers are excited about the trial on quantitative monitoring for paralysis after anesthesia because it promises more precise and reliable results compared to the traditional qualitative approach. Unlike qualitative monitoring, which relies on subjective assessments, quantitative monitoring uses objective measurements to detect neuromuscular function, potentially reducing the risk of residual paralysis. This method could lead to safer recoveries for patients by ensuring they regain full muscle control after surgery.
What evidence suggests that this trial's monitoring methods could be effective for improving recovery after anesthesia?
Research has shown that precise monitoring during surgery can greatly reduce the risk of muscle weakness after anesthesia. In this trial, participants will be assigned to either qualitative or quantitative monitoring. Some studies have found that quantitative monitoring, which provides accurate measurements, is more effective than older methods relying on personal judgment. By offering precise measurements, quantitative monitoring aids in a fuller and quicker recovery from anesthesia. This method is becoming common because it consistently leads to better patient outcomes.12356
Who Is on the Research Team?
Mehmet Turan, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
This trial is for patients undergoing non-cardiothoracic surgery who will receive neuromuscular blocking agents during anesthesia. The study aims to include those interested in how different monitoring methods might affect their recovery, particularly breathing function after surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either quantitative or qualitative neuromuscular block monitoring during non-cardiothoracic surgery
Recovery
Participants are monitored in the Post-Anesthesia Care Unit (PACU) for SpO2/FiO2 ratio
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Qualitative monitoring
- Quantitative monitoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor